RBP-1 |
E to K |
Retains binding to pRB |
ND |
[109] |
HBP-1 |
C to G in both LxCxE and LxCxE |
No binding to pRB |
Loss of transcriptional repression by HBPl |
[170] |
CtIP |
Deletion |
No binding to pRB |
ND |
[171] |
HDAC-1 |
Deletion |
No binding to pRB |
Inhibition of pRB repressive function |
[172,173] |
BRG-1 |
Mutation in pRB LxCxE cleft |
Retains binding to pRB |
ND |
[86] |
EID-1 |
Deletion |
No binding to pRB |
No effect |
[174] |
Gankyrin |
E to A |
No binding to pRB |
Inhibition of phosphorylation and degradation of pRB |
[110] |
RFC-1 |
C to G, E to K |
No binding to pRB |
Loss of RFC function in promoting cell survival after DNA damage |
[175] |
BRCA-1 |
RXRXH |
Retains binding to pRB |
Altered tumour suppressor activity of BRCA1 |
[111,172] |
ASK-1 |
LKCFE to VRCFD |
No binding to pRB |
Altered ASK-1 activity in induction of apoptosis |
[106] |
Cyclin D1, D2 |
C to G, E to K |
Profoundly diminished binding to pRB |
Partial abrogation of pRB-induced growth arrest and senescence |
[107,176] |
RBBP-9 |
L to Q |
No binding to pRB |
ND |
[177] |
NuMA |
C to G, E to K |
No binding to pRB |
Abnormal organization of spindle microtubules |
[178] |